Plain-English translation of NCT05044208 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This research study is looking at whether specific measurements from a heart ultrasound — particularly how the heart's upper chambers conduct electricity — can predict which patients will develop atrial fibrillation (an irregular heartbeat) after having a stroke or mini-stroke. The researchers will follow patients for two years using continuous heart monitoring devices to see if these ultrasound measurements can reliably spot who is at risk.
Atrial fibrillation is a common heart rhythm problem that causes about one-third of strokes, but many patients don't know they have it until it's too late. This study aims to find better ways to identify at-risk patients earlier using heart ultrasound, so doctors can catch irregular heartbeats sooner and prevent future strokes.
You likely qualify if…
You likely don't qualify if…
You would have a heart ultrasound performed and wear a portable heart rhythm monitor for seven days to record your heart's electrical activity. Then, the research team will follow you for two years, checking whether you develop irregular heartbeats through periodic monitoring — which may include additional heart monitors, implanted devices, or devices you already have if medically appropriate. The goal is to compare your heart ultrasound measurements with any irregular heartbeat patterns that appear during this follow-up period.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Austria
Sponsor
Karl Landsteiner University of Health Sciences
Collaborators
NÖ Landesgesundheitsagentur, legal entity of University Hospitals in Lower Austria, Department of Internal Medicine, University Hospital Tulln, Alter Ziegelweg 10, 3430, Tulln, Austria
Enrollment target
~200 participants
Started
January 2021
Primary completion
November 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Erol Erdik, MD
Head of Internal Medicine Department, University Hospital Tulln
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.